GATAD2A — patent landscape

Top predicted compounds (top 20 by supporting neighbours, then confidence)

	Compound	Confidence	Supporting neighbours

Clinical trials — most relevant to GATAD2A by text similarity (a relevance ranking, not an exhaustive list)

Trial	Phase	Status
Sirolimus Treatment for Newly Diagnosed Primary Acquired PRCA	PHASE4	COMPLETED
Deciphering Effects of Thalidomide on Red Blood Cells in Transfusion Dependents Beta Thalassemia Patients	PHASE3	COMPLETED
Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations	PHASE2	RECRUITING
Pilot and Feasibility Study of Reduced-Intensity Hematopoietic Stem Cell Transplant for MonoMAC	PHASE2	COMPLETED
A Phase II Study of Intravenous Azacitidine Alone in Patients With Myelodysplastic Syndromes	PHASE2	COMPLETED
PhII 5-Azacytidine Plus Valproic Acid and Eventually Atra in Intermediate II and High Risk MDS	PHASE2	COMPLETED
Treatment of Refractory Diamond-Blackfan Anemia With Eltrombopag	PHASE1/PHASE2	COMPLETED
Prolonged Release Pirfenidone Versus Placebo in Compensated Cirrhosis.	PHASE2	COMPLETED
Safety and Dose Escalation Study of Zinc Supplementation in Critically Ill Children	PHASE1/PHASE2	COMPLETED
Mobilization and Collection of Peripheral Blood Stem Cells in Patients With Fanconi Anemia Using G-CSF and AMD3100	PHASE1/PHASE2	COMPLETED
Natural History Study of GATA2 Deficiency and Related Disorders	nan	RECRUITING
EKLF Gene Expression in β-thalassemia	nan	NOT_YET_RECRUITING
EPIgenetics and in Vivo Resistance of Chronic Myeloid Leukemia Stem Cells to Tyrosine Kinase Inhibitors	nan	UNKNOWN
PHF19 Gene Expression and EZH2 Gene Deletion in Acute Myeloid Leukemia	nan	UNKNOWN
Gene Expression Variation and Implant Wound Healing Among Smokers and Diabetics	nan	COMPLETED
FoxO3a and PU.1 in Acute Lymphoblastic Leukemia	nan	UNKNOWN
Detection of Krupple Like Factor -1(KLF1/ EKLF) DNA Mutations in Beta Thalassemia Patients	nan	NOT_YET_RECRUITING
Studying The Role of Key Epigenetic Mediators in Breast Cancer Patients	nan	RECRUITING
The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.	nan	RECRUITING
RORC Genetic Polymorphism of Rheumatoid Arthritis	nan	COMPLETED
CML Pediatric ITK Response According to Molecular Identification at Diagnosis	nan	RECRUITING
Autophagy in Systemic Lupus Erythematosus	nan	UNKNOWN
Biocollection in MyeloDysplastic Syndrome (P-MDS)	nan	RECRUITING
DNA Methylation and Autoimmune Thyroid Diseases	nan	COMPLETED
Mild Intermittent Hypoxia and Its Multipronged Effect on Sleep Apnea	nan	RECRUITING
A Comparison of p53-induced Genes Activation in Patients With and Without Acute Myocardial Infarction	nan	COMPLETED
Characterization of New Candidate Genes in Cases of Human Inherited Thrombocytopenia (CATCH)	nan	COMPLETED
Family Resilience Initiative Research Program	nan	UNKNOWN
Diagnosis of RSTS: Identification of the Acetylation Profiles as Epigenetic Markers for Assessing Causality of CREBBP and EP300 Variants.	nan	UNKNOWN
Uterine Cavity Assessment and Endometrial Gene Expression in Tamoxifen Treated Breast Cancer Patients	nan	UNKNOWN

Related proteins — ESM-2 sequence neighbours (a GATAD2A binder may also engage these)

Protein	Name	Similarity
GATAD2B	Transcriptional repressor p66-beta	1.000	landscape →
Q8VHR5	—	0.996	Q8VHR5 →
Q8CHY6	—	0.995	Q8CHY6 →
Q9HCE3	—	0.982	Q9HCE3 →
Q9P2N5	—	0.982	Q9P2N5 →
Q5SFM8	—	0.980	Q5SFM8 →
Q9WU42	—	0.980	Q9WU42 →
Q8VHG2	—	0.979	Q8VHG2 →
Q80TM6	—	0.979	Q80TM6 →
Q8NEM7	—	0.979	Q8NEM7 →
P17544	—	0.979	P17544 →
A2AQ25	—	0.979	A2AQ25 →
P16951	—	0.978	P16951 →
Q5T5P2	—	0.978	Q5T5P2 →
O93602	—	0.978	O93602 →
Q6NXK2	—	0.978	Q6NXK2 →
Q96N64	—	0.977	Q96N64 →
Q3KR73	—	0.977	Q3KR73 →
P12755	—	0.977	P12755 →
Q5R9C9	—	0.977	Q5R9C9 →
NCOR2	Nuclear receptor corepressor 2	0.977	landscape →
Q9P2N6	—	0.977	Q9P2N6 →
Q9Z103	—	0.977	Q9Z103 →
Q8N228	—	0.976	Q8N228 →
Q9P270	—	0.976	Q9P270 →
A0JNC2	—	0.976	A0JNC2 →
Q6ZNC4	—	0.976	Q6ZNC4 →
A2RSY1	—	0.975	A2RSY1 →
Q8N9M1	—	0.975	Q8N9M1 →
Q8ND83	—	0.975	Q8ND83 →